The below is from FNN:
Pharmaxis Limited (ASX:PXS) has extended its first half net loss by 6 per cent to $20.8 million and declined to pay a dividend. The pharmaceutical company’s first half revenue jumped 77 per cent to almost $6 billion as it shipped its first commercial product Aridol to customers around the world. Shares in Pharmaxis have slipped 2.34 per cent and are trading at $0.63.
The revenue only from Aridol is eye catching $6bn !!!!
Vow this is def. a bargain of the century at current prices with or without Bronchitol!!
DYOR
Ann: Half Year Report and Accounts , page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
-0.003(9.68%) |
Mkt cap ! $37.01M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.0¢ | 2.8¢ | $142.8K | 4.980M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 899111 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 156978 | 4 |
View Market Depth
| Last trade - 10.32am 06/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |